Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract

Human Pathology

Volumn 34, Issue 9, 2003, Pages 902-910

  Abraham, Susan C ^a   Lee, Jae Hyuk ^b   Hruban, Ralph H ^b   Argani, Pedram ^b   Furth, Emma E ^b   Wu, Tsung Teh ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Biliary tract; Cholangiocarcinoma; Intraductal papillary neoplasm; Liver

Indexed keywords

BETA CATENIN;

ADULT; AGED; ALLELIC EXCLUSION; ARTICLE; BETA CATENIN GENE; BILE DUCT CARCINOMA; BILIARY TRACT TUMOR; CARCINOGENESIS; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 5Q; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; DPC4 GENE; EXON; FEMALE; GENE LOCUS; GENE LOSS; GENE MUTATION; HEPATOBILIARY SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INTRADUCTAL PAPILLARY NEOPLASM; MALE; MALIGNANT TRANSFORMATION; MOLECULAR PATHOGENESIS; ONCOGENE; ONCOGENE K RAS; PANCREAS TUMOR; PATHOGENESIS; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0141429117     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00337-X     Document Type: Article

References (63)

1. Loh A, Kamar S, Dickson GH: Solitary benign papilloma (papillary adenoma) of the cystic duct: A rare cause of biliary colic. Br J Clin Pract 48:167-168, 1994
2. Hubens G, Delvaux G, Willems G, et al: Papillomatosis of the intra- and extrahepatic bile ducts with involvement of the pancreatic duct. Hepatogastroenterology 38:413-418, 1991
3. Seo DW, Lee SK, Kim MH: Biliary papillomatosis. Gastrointest Endosc 51:67, 2000
4. Baillie J: Tumors of the gallbladder and bile ducts. J Clin Gastroenterol 29:14-21, 1999
5. Bronnimann S, Zimmermann A, Baer HU: Diffuse bile duct papillomatosis: High rate of recurrence and risk of malignant transformation. Chirurg 67:93-97, 1996
6. Callea F, Sergi C, Fabbretti G, et al: Precancerous lesions of the biliary tree. J Surg Oncol Suppl 3:131-133, 1993
7. Cheng MS, AhChong AK, Mak KL, et al: Case report: Two cases of biliary papillomatosis with unusual associations. J Gastroenterol Hepatol 14:464-467, 1999
8. Colombari R, Tsui W: Biliary tumors of the liver. Semin Liver Dis 15:402-413, 1995
9. Gertsch P, Thomas P, Baer H, et al: Multiple tumors of the biliary tract. Am J Surg 159:386-388, 1990
10. Kim YS, Myung SJ, Kim SY, et al: Biliary papillomatosis: Clinical, cholangiographic and cholangioscopic findings. Endoscopy 30:763-767, 1998
11. Ohta H, Yamaguchi Y, Yamakawa O, et al: Biliary papillomatosis with the point mutation of K-ras gene arising in congenital choledochal cyst. Gastroenterology 105:1209-1212, 1993
12. Sagar PM, Omar M, Macrie J: Extrahepatic biliary papillomatosis occurring after removal of a dysplastic gallbladder. HPB Surg 6:219-221, 1993
13. Taguchi J, Yasunaga M, Kojiro M, et al: Intrahepatic and extrahepatic biliary papillomatosis. Arch Pathol Lab Med 117:944-947, 1993
14. Terada T, Mitsui T, Nakanuma Y, et al: Intrahepatic biliary papillomatosis arising in nonobstructive intrahepatic biliary dilatations confined to the hepatic left lobe. Am J Gastroenterol 86:1523-1526, 1991
15. Tireli M, Uslu A: Multiple biliary papillomatosis. HPB Surg 6:125-127, 1992
16. Chae BW, Chung JP, Park YN, et al: Villous adenoma of the bile ducts: A case report and a review of the reported cases in Korea. Yonsei Med J 40:84-89, 1999
17. Kim HJ, Kim MH, Lee SK, et al: Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy 32: 389-393, 2000
18. Nakanuma Y, Sripa B, Vantanasapt V, et al: Intrahepatic cholangiocarcinoma, in Hamilton SR, Aaltonen LA (eds): World Health Organization Classification of Tumors, Pathology and Genetics: Tumors of the Digestive System. Lyon, France, IARC Press, 2000, pp 173-180
19. Chen T-C, Nakanuma Y, Zen Y, et al: Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34:651-658, 2001
20. Shimonishi T, Zen Y, Chen TC, et al: Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. HUM PATHOL 33:503-511, 2002
21. Adolphs HD, Schlachetzki J, Breining H, et al: Malignant papillomatosis of the extrahepatic bile ducts. Med Klin 69:1899-1902, 1974
22. Helpap B: Malignant papillomatosis of the intrahepatic bile ducts. Acta Hepatogastroenterol 24:419-425, 1977
23. Neumann RD, LiVolsi VA, Rosenthal NS, et al: Adenocarcinoma in biliary papillomatosis. Gastroenterology 70:779-782, 1976
24. Fujii H, Inagaki M, Kasai S, et al: Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 151:1447-1454, 1997
25. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al: Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: Comparison with conventional ductal adenocarcinomas. Am J Pathol 157:755-761, 2000
26. Islam HK, Fujioka Y, Tomidokoro T, et al: Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas - Diagnostic and biologic significance. Hepatogastroenterology 46:2599-2605, 1999
27. Luttges J, Zamboni G, Longnecker D, et al: The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 25:942-948, 2001
28. Sakai Y, Yanagisawa A, Shimada M, et al: K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas. HUM PATHOL 31:795-803, 2000
29. Satoh K, Shimosegawa T, Moriizumi S, et al: K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 12:362-368, 1996
30. Sessa F, Solcia E, Capella C, et al: Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53, and c-erbB-2 abnormalities in 26 patients. Virchows Arch 425:357-367, 1994
31. Tada M, Omata M, Ohto M: Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases. Cancer 67:634-637, 1991
32. Z'graggen K, Rivera JA, Compton CC, et al: Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 226:491-498, 1997
33. Solcia E, Capella C, Kloppel G: Tumors of the exocrine pancreas, in Solcia E, Capella C, Kloppel G (eds): Atlas of Tumor Pathology, Tumors of the Pancreas, Third series, Fascicle 20. Washington, DC, Armed Forces Institute of Pathology, 1997, pp 31-144
34. Longnecker DS, Adler G, Hruban RH, et al: Intraductal papillary-mucinous neoplasms of the pancreas, in Hamilton SR, Aaltonen LA (eds): World Health Organization Classification of Tumours, Pathology and Genetics: Tumours of the Digestive System. Lyon, France, IARC Press, 2000, pp 237-240
35. Adsay NV, Longnecker DS, Klimstra DS: Pancreatic tumors with cystic dilatation of the ducts: Intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 17:16-30, 2000
36. Baas IO, Mulder JW, Offerhaus GJ, et al: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172:5-12, 1994
37. Wilentz RE, Su GH, Dai JL, et al: Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation. Am J Pathol 156:37-43, 2000
38. Moskaluk CA, Kern SE: Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 150:1547-1552, 1997
39. Wu TT, Watanabe T, Heitmiller R, et al: Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 153:287-294, 1998
40. Abraham SC, Lee JH, Boitnott JK, et al: Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol 15:1309-1319, 2002
41. Albores-Saavedra J, Henson DE, Klimstra DS: Benign epithelial tumors and papillomatosis of the extrahepatic bile ducts, in Albores-Saavedra J, Henson DE, Klimstra DS (eds): Atlas of Tumor Pathology: Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater, Third series, Fascicle 27. Washington, DC, Armed Forces Institute of Pathology, 2000, pp 171-180
42. Satoh S, Daigo Y, Furukawa Y, et al: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245-250, 2000
43. deWinter JP, Roelen BA, ten Dijke P, et al: DPC4 (SMAD4) mediates transforming growth factor-β 1 (TGF-β 1) - induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14:1891-1899, 1997
44. Argani P, Shaukat A, Kaushal M, et al: Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer 91:1332-1341, 2001
45. Hahn SA, Bartsch D, Schroers A, et al: Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58:1124-1126, 1998
46. Schutte M, Hruban RH, Hedrick L, et al: DPC4 gene in various tumor types. Cancer Res 56:2527-2530, 1996
47. Furubo S, Harada K, Shimonishi T, et al: Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma. Histopathology 35:230-240, 1999
48. Kang YK, Kim WH, Lee HW, et al: Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. Lab Invest 79:477-483, 1999
49. Kiba T, Tsuda H, Pairojkul C, et al: Mutations of the p53 tumor-suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol Carcinog 8:312-318, 1993
50. Lee JC, Lin PW, Lin YJ, et al: Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections. J Formos Med Assoc 94:719-723, 1995
51. Ohashi K, Nakajima Y, Kanehiro H, et al: Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: Relation to gross tumor morphology. Gastroenterology 109:1612-1617, 1995
52. Ohashi K, Tsutsumi M, Nakajima Y, et al: High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas. Jpn J Clin Oncol 24:305-310, 1994
53. Petmitr S, Pinlaor S, Thousungnoen A, et al: K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients. Southeast Asian J Trop Med Public Health 29:71-75, 1998
54. Sturm PD, Baas IO, Clement MJ, et al: Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area. Int J Cancer 78:695-698, 1998
55. Tada M, Omata M, Ohto M: Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 50:1121-1124, 1990
56. Tada M, Omata M, Ohto M: High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer 69:1115-1118, 1992
57. Wattanasirichaigoon S, Tasanakhajorn U, Jesadapatarakul S: The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique. J Med Assoc Thai 81:316-323, 1998
58. Almoguera C, Shibata D, Forrester K, et al: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554, 1988
59. Hruban RH, Goggins M, Parsons J, et al: Progression model for pancreatic cancer. Clin Cancer Res 6:2969-2972, 2000
60. Kang YK, Kim YI, Kim WH: Allelotype analysis of intrahepatic cholangiocarcinoma. Mod Pathol 13:627-631, 2000
61. Luttges J, Galehdari H, Brocker V, et al: Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158:1677-1683, 2001
62. Rashid A, Gao YT, Bhakta S, et al: Beta-catenin mutations in biliary tract cancers. A population-based study in China. Cancer Res 61:3406-3409, 2001
63. Iacobuzio-Donahue CA, Abraham SC, Klimstra DS, et al: Beta-catenin and APC are low-frequency mutational targets in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. Mod Pathol 15:287A, 2002